BIOMAT Database Logo BIOMAT Database Logo

Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants. 1980

D C Poskanzer, and P I Terasaki, and L B Prenney, and J L Sheridan, and M S Park

Histocompatibility testing was performed in 48 multiple sclerosis patients and two carefully matched control groups in Orkney Islands, an area of high multiple sclerosis prevalence. The frequency of HLA-A3, HLA-B7, and DW2 was comparable in patients and controls. However, HLA-B7 was significantly more common in female patients compared with male patients. A B-cell alloantigen (B-cell 4) was also as frequent in patients as among controls. Strong linkage between HLA-B7, DW2 and B-cell 4 occurred in controls, but not patients; the linkage was particularly striking in female controls. These data are not consistent with theories that relate certain of the histocompatibility antigens to the aetiology of multiple sclerosis.

UI MeSH Term Description Entries
D007519 Isoantigens Antigens that exist in alternative (allelic) forms in a single species. When an isoantigen is encountered by species members who lack it, an immune response is induced. Typical isoantigens are the BLOOD GROUP ANTIGENS. Alloantigens,Alloantigen,Isoantigen
D008040 Genetic Linkage The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME. Genetic Linkage Analysis,Linkage, Genetic,Analyses, Genetic Linkage,Analysis, Genetic Linkage,Genetic Linkage Analyses,Linkage Analyses, Genetic,Linkage Analysis, Genetic
D008297 Male Males
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D005260 Female Females
D006113 United Kingdom Country in northwestern Europe including Great Britain and the northern one-sixth of the island of Ireland, located between the North Sea and north Atlantic Ocean. The capital is London. Great Britain,Isle of Man
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000949 Histocompatibility Antigens Class II Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen. Antigens, Immune Response,Class II Antigens,Class II Histocompatibility Antigen,Class II Major Histocompatibility Antigen,Ia Antigens,Ia-Like Antigen,Ia-Like Antigens,Immune Response Antigens,Immune-Associated Antigens,Immune-Response-Associated Antigens,MHC Class II Molecule,MHC II Peptide,Class II Antigen,Class II Histocompatibility Antigens,Class II MHC Proteins,Class II Major Histocompatibility Antigens,Class II Major Histocompatibility Molecules,I-A Antigen,I-A-Antigen,IA Antigen,MHC Class II Molecules,MHC II Peptides,MHC-II Molecules,Antigen, Class II,Antigen, I-A,Antigen, IA,Antigen, Ia-Like,Antigens, Class II,Antigens, Ia,Antigens, Ia-Like,Antigens, Immune-Associated,Antigens, Immune-Response-Associated,I A Antigen,II Peptide, MHC,Ia Like Antigen,Ia Like Antigens,Immune Associated Antigens,Immune Response Associated Antigens,MHC II Molecules,Molecules, MHC-II,Peptide, MHC II,Peptides, MHC II
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent

Related Publications

D C Poskanzer, and P I Terasaki, and L B Prenney, and J L Sheridan, and M S Park
Studies in the epidemiology of multiple sclerosis in the Orkney and Shetland Islands.
June 1976, Neurology,
D C Poskanzer, and P I Terasaki, and L B Prenney, and J L Sheridan, and M S Park
Multiple sclerosis in the Orkney and Shetland Islands and in north-east Scotland.
February 1981, British medical journal (Clinical research ed.),
D C Poskanzer, and P I Terasaki, and L B Prenney, and J L Sheridan, and M S Park
Multiple sclerosis in the Orkney and Shetland Islands. I: Epidemiology, clinical factors, and methodology.
December 1980, Journal of epidemiology and community health,
D C Poskanzer, and P I Terasaki, and L B Prenney, and J L Sheridan, and M S Park
Multiple sclerosis in the Orkney and Shetland Islands. II: The search for an exogenous aetiology.
December 1980, Journal of epidemiology and community health,
D C Poskanzer, and P I Terasaki, and L B Prenney, and J L Sheridan, and M S Park
Multiple sclerosis in the Orkney and Shetland Islands. IV: Viral antibody titres and viral infections.
December 1980, Journal of epidemiology and community health,
D C Poskanzer, and P I Terasaki, and L B Prenney, and J L Sheridan, and M S Park
Multiple sclerosis in the Orkney and Shetland Islands. VI: The effects of migration and social structure.
December 1980, Journal of epidemiology and community health,
D C Poskanzer, and P I Terasaki, and L B Prenney, and J L Sheridan, and M S Park
Genome-wide homozygosity and multiple sclerosis in Orkney and Shetland Islanders.
February 2012, European journal of human genetics : EJHG,
D C Poskanzer, and P I Terasaki, and L B Prenney, and J L Sheridan, and M S Park
The prevalence of multiple sclerosis in the Outer Hebrides compared with north-east Scotland and the Orkney and Shetland Islands.
June 1981, Journal of epidemiology and community health,
D C Poskanzer, and P I Terasaki, and L B Prenney, and J L Sheridan, and M S Park
Multiple sclerosis in the Shetland Islands: an update.
February 1988, Acta neurologica Scandinavica,
D C Poskanzer, and P I Terasaki, and L B Prenney, and J L Sheridan, and M S Park
Declining incidence of multiple sclerosis in the Orkney Islands.
April 1985, Neurology,
Copied contents to your clipboard!